GLS2 and diabetic kidney disease: Given that GLS2 is the gatekeeper for the conversion of Gln to Glu, an indispensable process for Gln to enter the tricarboxylic acid (TCA) cycle (Figure 2H), these findings suggest that the inhibited GLS2‐derived glutaminolysis could promote the accumulation of Gln in glomeruli with DKD.